
Lymphoma Research Foundation profiles BC Cancer's David Scott, MBCHB, PhD
Researcher Spotlight: David Scott, MBCHB, PhD
The disease course for follicular lymphoma (FL) is highly variable, and while many patients respond to treatment, some may experience relapse or evolution of disease into a more aggressive form of lymphoma. By studying genetic mutations, gene and protein expression, and interactions between lymphoma cells and their environment, Dr. Scott’s LRF research aims to develop tools that can reliably predict patient outcomes and guide treatment decision-making.